Neuraptive Therapeutics begins patient enrollment in NTX-001 facial paralysis trial
Neuraptive Therapeutics said that it has enrolled the first patient in its phase 2a clinical trial of NTX-001 for the treatment and prevention of facial ... Read More
ATAI Life Sciences partners with Neuronasal to develop concussion treatment
ATAI Life Sciences, a German biotech company focused on developing drugs for mental illnesses, has partnered with Neuronasal to develop a short-term treatment for mild ... Read More
Dealing with your emotions following a car accident
In most parts of a person’s daily routine, you can’t leave the house without coming in to contact with cars and traffic. Whether you are ... Read More